Hepatocellular Carcinoma
Hepatocellular carcinoma is cancer that starts in the liver. It is the most common form of primary liver cancer, meaning the tumour originates in the liver rather than spreading there from another site.
Key points
- Hepatocellular carcinoma often develops in a liver already damaged by long-term conditions such as cirrhosis or chronic hepatitis.
- The listed medicine contains sorafenib, a targeted therapy that interferes with signals cancer cells use to grow and divide.
The only medicine listed for hepatocellular carcinoma contains Sorafenib, a targeted therapy. It belongs to a class of drugs that interferes with signals cancer cells use to grow and divide. Sorafenib is taken as a tablet.
